Page History

Synopsis:

Genome-directed cancer therapy holds great promise for the future of cancer treatment; however, many challenges remain.  This talk will review the informatics challenges and solutions related to the Vanderbilt Personalized Cancer Medicine Initiative.  Dr. Mia Levy will present Vanderbilt’s initial solution including how tumor gene-mutation testing results were integrated into the electronic health record with a link to a decision-support knowledge service to assist providers in understanding actionable gene-directed therapies including local and national clinical trials.  The resource, called “My Cancer Genome,” is now publicly available at MyCancerGenome.org. Dr. Levy will describe the development and maintenance of this application including the annotation of the National Cancer Institute PDQ clinical trial registry with gene associations. Session details ...